Embed Size (px)
Citation preview
GLOBAL INDUSTRY INSIGHT: Osteoporosis Drugs Market Size, Share, Development, Growth and
Demand Forecast to 2020
© P&S Market Research. All rights reserved 2
Global Osteoporosis Drugs Market Size, Share, Development,
Growth and Demand Forecast to 2020
The osteoporosis drugs market is increasing at a significant rate, due to increase in aging population, increasing
incidence of osteoporosis in post-menopausal females and growing appreciation of osteoporosis care by the
consumers. Increasing concentration on research and development for advanced osteoporosis drugs is providing
ample opportunities for the osteoporosis drugs market to grow in the coming years.
North America leads the osteoporosis drugs market, due to increasing investment on research and development
in the region for innovation of advanced drugs, growing aging population and increasing occurrence of lifestyle
related diseases. The Asia-Pacific osteoporosis drugs market is expected to grow with an exponential rate in the
coming years. India and China are the growing with the highest rate in osteoporosis drugs market. The highest
growth rate of the countries is, due to huge pool of patients, growing healthcare expenditure, increasing geriatric
population, modifying lifestyles and rising appreciation of osteoporosis care.
Explore more about Osteoporosis Drugs Market: https://www.psmarketresearch.com/market-
analysis/osteoporosis-drugs-market
Osteoporosis disease occurs due to reduced bone mineral density, which causes increased risk of fractures and
fragile bones. Bone mineral density decreases naturally with age, thus aging population is facing high risks of
osteoporosis disease. The decline in bone strength is only visible after the bone gets fractured. Most of the spine,
hip and forearm fractures occur within aged people of 65 years and above. . The consumers having a family
history of the osteoporosis disease are at intensified risk of the disease, since it is a heritable disease. Especially,
the consumers from Asian and European origins have more risks of osteoporosis disease. One of the major
procedures to build stronger muscle and bones is exercising regularly during the teenage years, which in turn
leads to a lower risk of osteoporosis disease. The increasing trend of inactive lifestyle and obesity leads to
growing prevalence of osteoporosis disease.
Some of the signs and symptoms of the osteoporosis are falling risk and fractures. Diagnostics tests of
osteoporosis include biomarkers, dual energy X-Ray test and traditional radiography tests. Osteoporosis disease
can be managed by nutrition emphasis, lifestyle management and medicines. Duavee, romosozumab and
odanacatib are some of the drugs for osteoporosis disease that are under development stage.
The osteoporosis drugs market can be categorized on the basis of drug class into antiresorptive drugs and
anabolic drugs. Antiresorptive drugs include RANKL antibodies, selective oestrogen receptor modulators,
calcitonin salmon, cathepsin K inhibitors, bisphosphonates, binosto and protelos. Anabolic drugs include,
blosozumab, human recombinant parathyroid hormones, BA-058, PTH (1-31) NH2, anti sclerostin monoclonal
antibodies, preotact, ZT-034 and ZP-PTH.
© P&S Market Research. All rights reserved 3
Global Osteoporosis Drugs Market Size, Share, Development,
Growth and Demand Forecast to 2020
Establishment of advanced drug classes with greater efficiency to overcome the risk of side effects and generics
is the major factors driving the growth of osteoporosis drugs market to some extent. Complications and side
effects of the osteoporosis drugs such as, nausea, irritable bowel syndrome and ulcers in stomach is affecting the
growth of the osteoporosis drugs market to some extent. Strict regulatory standards such as, Phase IV
investigations and patent expiries of drugs are the factors restraining growth of the osteoporosis drugs market.
Request Table of Contents: https://www.psmarketresearch.com/enquiry-form.php?enqid=267&title=TOC
Some of the competitors in the osteoporosis drugs market are, Eli Lilly and Company, Teva Pharmaceutical
Industries Ltd., Merck & Co, Inc., F. Hoffmann La Roche Ltd., Novo Nordisk A/S, Actavis PLC, Novartis
International AG, Amgen, Inc., and Pfizer, Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for
various geographies around the globe. We provide market research reports, industry forecasting reports,
business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate
forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through
their interaction with leading companies of the concerned domain. We help our clients with B2B market research
and assist them in identifying various windows of opportunity, and framing informed and customized business
expansion strategies in different regions.
Contact:
Ms. Somya
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Web: https://www.psmarketresearch.com
